S. Munier

发表

Cationic PLA nanoparticles for DNA delivery: comparison of three surface polycations for DNA binding, protection and transfection properties.

T. Delair, B. Verrier, S. Munier, 2005, Colloids and surfaces. B, Biointerfaces.

Surfactant-free anionic PLA nanoparticles coated with HIV-1 p24 protein induced enhanced cellular and humoral immune responses in various animal models.

Roger Le Grand, Céline Terrat, Bernard Verrier, 2006, Journal of controlled release : official journal of the Controlled Release Society.

Coadsorption of HIV-1 p24 and gp120 proteins to surfactant-free anionic PLA nanoparticles preserves antigenicity and immunogenicity.

T. Delair, B. Verrier, S. Munier, 2006, Journal of controlled release : official journal of the Controlled Release Society.

Formulation of HIV-1 Tat and p24 antigens by PLA nanoparticles or MF59 impacts the breadth, but not the magnitude, of serum and faecal antibody responses in rabbits.

T. Delair, B. Verrier, S. Munier, 2007, Vaccine.

Poly(d,l-lactic acid) and chitosan complexes: interactions with plasmid DNA

T. Delair, B. Verrier, S. Munier, 2005 .

Intradermal immunization triggers epidermal Langerhans cell mobilization required for CD8 T-cell immune responses.

D. Duffy, B. Verrier, S. Munier, 2012, The Journal of investigative dermatology.

Elaboration of poly(ethyleneimine) coated poly(D, L-lactic acid) particles. Effect of ionic strength on the surface properties and DNA binding capabilities

T. Delair, B. Verrier, S. Munier, 2003 .

Targeting of HIV-p24 particle-based vaccine into differential skin layers induces distinct arms of the immune responses.

D. Duffy, B. Verrier, R. Shattock, 2011, Vaccine.

Loading dendritic cells with PLA-p24 nanoparticles or MVA expressing HIV genes induces HIV-1-specific T cell responses.

Felipe García, J. Gatell, T. Gallart, 2014, Vaccine.

Towards biocompatible vaccine delivery systems: interactions of colloidal PECs based on polysaccharides with HIV-1 p24 antigen.

T. Delair, B. Verrier, S. Munier, 2008, Biomacromolecules.

Particle-based transcutaneous administration of HIV-1 p24 protein to human skin explants and targeting of epidermal antigen presenting cells.

S. Hackbarth, B. Verrier, S. Munier, 2014, Journal of controlled release : official journal of the Controlled Release Society.

Design and characterization of an HIV-1 Tat mutant: inactivation of viral and cellular functions but not antigenicity.

B. Verrier, S. Munier, A. Beck, 2007, Vaccine.